This article is an orphan, as no other articles link to it . Please introduce links to this page from related articles ; try the Find link tool for suggestions. (August 2024) |
Mark Anthony Febbraio | |
---|---|
Occupation(s) | Physiologist, academic and researcher |
Awards | UNSW Eureka Prize for Scientific Research, Australian Museum (2020) GSK Award for Research Excellence, GSK (2020) |
Academic background | |
Education | PhD |
Alma mater | University of Victoria (Australia) |
Academic work | |
Institutions | Monash University National Health and Medical Research Council (NHMRC) |
Mark Anthony Febbraio is a physiologist,academic and researcher. He is a professor and head of the Cellular and Molecular Metabolism Laboratory at the Monash Institute of Pharmaceutical Sciences (MIPS) of Monash University and a Senior Principal Research Fellow of the National Health and Medical Research Council (NHMRC). [1]
Febbraio's research focuses on the mechanisms linked to exercise,obesity,type 2 diabetes,and cancer,to develop drugs to treat lifestyle-related diseases. He has received several awards including the 1999 A K McIntyre Prize for significant contributions to Australian Physiological Science, [2] the 2017 Kellion Award from the Australian Diabetes Society (ADS), [3] the 2020 UNSW Eureka Prize for Scientific Research from the Australian Museum, [4] the 2020 GSK Award for Research Excellence, [5] the 2021 International Medal from the Society for Endocrinology [6] and the Kirsten and Freddy Johansen Rigshospitalet International Award for Danish Medical Science. [7]
Febbraio has delivered several named lectures,including the Colin I Johnson Lectureship by the High Blood Pressure Research Council of Australia (2006),the ESA/ADS Joint Plenary Lecture (2009), [8] the Sandford Skinner Oration (2011),The Kellion Lecture (2017) and The AuPS Invited Lecture 2024. [9] He is The Deputy Editor in Chief of the Journal of Sport &Health Sciences. [10]
Febbraio completed his undergraduate degree in Applied Sciences (Physical Education) (1987) and has a Diploma of Education on Science from Hawthorn Institute of Education (1989). He obtained his PhD in Chemistry and Biology (1994) at Victoria University in Footscray,Victoria,Australia. [11]
Febbraio served on the Council of the Australian Diabetes Society from 2004 to 2008,including a term as Honorary Treasurer from 2006 to 2008. He has held a position on the board of directors for the Centre for Physical Activity Research in Copenhagen and is a member of the Healthier Lives International Science Advisory Panel in New Zealand. [12] He was lllHead of lllDiabetes and lllMetabolism at the Garvan Institute of Medical Research. [13] He discovered that the HSP72 activator BGP-15 can ameliorate insulin resistance in mice,leading to his appointment as lllChief lllScientific lllOfficer of N-Gene Pharmaceuticals. [14] His HSP72 project grant was also named one of the “Ten of the Best”by the NHMRC in 2012. [15] He holds an appointment as a professor and head of the Cellular and Molecular Metabolism Laboratory within the Drug Discovery Program at MIPS and is a senior principal research fellow at the NHMRC. [16]
Febbraio has been involved in community leadership by participating in the Williamson Community Leadership Program by the Victoria State Government [17] and co-hosting the radio show "The Science of Sport" on the SEN radio network from 2014 to 2018,focusing on the health benefits of regular physical activity. [18]
Febbraio spent some time (1988–1990) competing in Ironman Triathlon at the International Level. He was a member of JAL Team Australia (1990) an completed the 1989 Ironman Triathlon World Championships in Kona,Hawaii,USA. [19]
Febbraio's work highlights his co-discovery that contracting skeletal muscles secrete endocrine factors called myokines,which influence the biology of other organs. This finding advanced his research into the molecular mechanisms behind the health benefits of exercise and its disease-preventive effects by demonstrating that myokines can protect against metabolic diseases and certain cancers,leading to the development of a new class of drugs targeting these conditions through the identification of crucial genes,proteins,and pathways. [20] He has secured grants from the Australian Research Council,NIH,and Diabetes Australia Research Trust,and his discoveries have earned him patents in the field. [21] [22]
Febbraio,along with Bente Pedersen from the University of Copenhagen,found that skeletal muscle had the ability to produce and release proteins known as true endocrine factors,leading them to introduce the term "myokine". [23] He furthered the understanding of interleukin 6 (IL-6) as a myokine,demonstrating through human infusion studies that exercise-released IL-6 stimulated liver glucose production to support muscle nutrient supply. [24] In a subsequent study,his lab demonstrated that IL-6 acted as a powerful insulin sensitizer,shedding light on exercise's therapeutic potential for metabolic diseases. This discovery thrusted IL-6 into investigations on how exercise influenced insulin action and metabolism. [25]
One of Febbraio's highly cited studies discussed the role of skeletal muscle as an endocrine organ,focusing on the myokine IL-6,its regulation by exercise,its signaling pathways,and its metabolic impact on health and disease. [26] Building upon his work on IL-6,he reviewed the mechanisms and biological roles of muscle-derived IL-6 in response to exercise and its potential as a therapeutic drug for metabolic disorders. [27] He also looked into the role of TNF-α,reviewing how physical exercise and IL-6 infusion inhibit endotoxin-induced TNF-αproduction,providing evidence that exercise mediates anti-inflammatory activity through muscle-released IL-6. [28]
In 2006,Febbraio discovered that ciliary neurotrophic factor (CNTF),a cytokine related to IL-6,can prevent obesity and insulin resistance. [29] In related research,he referred to the trans-signaling process,where a soluble form of a receptor (such as sgp130) enables signaling by a cytokine (like IL-6) that would otherwise require a membrane-bound receptor. He then demonstrated that overexpression of sgp130Fc effectively blocked IL-6 trans-signaling,preventing macrophage infiltration into adipose tissue in obesity. [30] His discoveries led him to develop IC7Fc,a synthetic IL-6/CNTF chimeric peptide,which activated the gp130 receptor signalling complex. His paper published in Nature demonstrated IC7Fc's efficacy in improving glucose tolerance,reducing hyperglycemia,and preventing weight gain and liver steatosis in obese mice. [31]
Febbraio's collaborative work also introduced the concept that communication between tissues during exercise is facilitated by extracellular vesicles (EVs),which are lipid-bound vesicles released by cells into the extracellular space and transport proteins and miRNA. [32] This discovery,noted for its significant impact,led to ongoing research into EVs' roles in diseases like fatty liver disease and cancers,along with the paper being highlighted by a feature article in the New York Times titled The Mysterious Interior World of Exercise. [33]
Insulin resistance (IR) is a pathological condition in which cells either fail to respond normally to the hormone insulin or downregulate insulin receptors in response to hyperinsulinemia.
Tumor necrosis factor ('TNF),also known as cachexin or cachectin,is a cytokine and a member of the TNF superfamily,which comprises various transmembrane proteins with a homologous TNF domain. Initially referred to as TNFα,this cytokine was the first to be identified as an adipokine,secreted by adipose tissue. TNF signaling occurs through two receptors:TNFR1 and TNFR2. TNFR1 is widely expressed across most cell types and is typically associated with pro-inflammatory and apoptotic signaling. In contrast,TNFR2 is mainly found on endothelial,epithelial,and immune cells,where it mediates anti-inflammatory responses and promotes cell proliferation.
Exercise physiology is the physiology of physical exercise. It is one of the allied health professions,and involves the study of the acute responses and chronic adaptations to exercise. Exercise physiologists are the highest qualified exercise professionals and utilise education,lifestyle intervention and specific forms of exercise to rehabilitate and manage acute and chronic injuries and conditions.
Adiponectin is a protein hormone and adipokine,which is involved in regulating glucose levels and fatty acid breakdown. In humans,it is encoded by the ADIPOQ gene and is produced primarily in adipose tissue,but also in muscle and even in the brain.
Resistin also known as adipose tissue-specific secretory factor (ADSF) or C/EBP-epsilon-regulated myeloid-specific secreted cysteine-rich protein (XCP1) is a cysteine-rich peptide hormone derived from adipose tissue that in humans is encoded by the RETN gene.
Interleukin 6 (IL-6) is an interleukin that acts as both a pro-inflammatory cytokine and an anti-inflammatory myokine. In humans,it is encoded by the IL6 gene.
A branched-chain amino acid (BCAA) is an amino acid having an aliphatic side-chain with a branch. Among the proteinogenic amino acids,there are three BCAAs:leucine,isoleucine,and valine. Non-proteinogenic BCAAs include 2-aminoisobutyric acid and alloisoleucine.
Glucose transporter type 4 (GLUT4),also known as solute carrier family 2,facilitated glucose transporter member 4,is a protein encoded,in humans,by the SLC2A4 gene. GLUT4 is the insulin-regulated glucose transporter found primarily in adipose tissues and striated muscle. The first evidence for this distinct glucose transport protein was provided by David James in 1988. The gene that encodes GLUT4 was cloned and mapped in 1989.
The unfolded protein response (UPR) is a cellular stress response related to the endoplasmic reticulum (ER) stress. It has been found to be conserved between mammalian species,as well as yeast and worm organisms.
Sarcopenic obesity is a combination of two disease states,sarcopenia and obesity. Sarcopenia is the muscle mass/strength/physical function loss associated with increased age,and obesity is based off a weight to height ratio or body mass index (BMI) that is characterized by high body fat or being overweight.
Fibronectin type III domain-containing protein 5,the precursor of irisin,is a type I transmembrane glycoprotein that is encoded by the FNDC5 gene. Irisin is a cleaved version of FNDC5,named after the Greek messenger goddess Iris.
Michael Cowley FTSE is an Australian physiologist. He is best known for his mapping of the neural circuits involved in metabolism and obesity and diabetes treatment. He is a professor in the Department of Physiology at Monash University in the Faculty of Biomedical and Psychological Sciences. He is also a director of the Australian diabetes drug development company,Verva Inc,and director of the Monash Obesity &Diabetes Institute] (modi).
Anti-interleukin-6 agents are a class of therapeutics. Interleukin 6 is a cytokine relevant to many inflammatory diseases and many cancers. Hence,anti-IL6 agents have been sought. In rheumatoid arthritis they can help patients unresponsive to TNF inhibitors.
A myokine is one of several hundred cytokines or other small proteins and proteoglycan peptides that are produced and released by skeletal muscle cells in response to muscular contractions. They have autocrine,paracrine and/or endocrine effects;their systemic effects occur at picomolar concentrations.
The sympathoadrenal system is a physiological connection between the sympathetic nervous system and the adrenal medulla and is crucial in an organism's physiological response to outside stimuli. When the body receives sensory information,the sympathetic nervous system sends a signal to preganglionic nerve fibers,which activate the adrenal medulla through acetylcholine. Once activated,norepinephrine and epinephrine are released directly into the blood by adrenomedullary cells where they act as the bodily mechanism for "fight-or-flight" responses. Because of this,the sympathoadrenal system plays a large role in maintaining glucose levels,sodium levels,blood pressure,and various other metabolic pathways that couple with bodily responses to the environment. During numerous diseased states,such as hypoglycemia or even stress,the body's metabolic processes are skewed. The sympathoadrenal system works to return the body to homeostasis through the activation or inactivation of the adrenal gland. However,more severe disorders of the sympathoadrenal system such as pheochromocytoma can affect the body's ability to maintain a homeostatic state. In these cases,curative agents such as adrenergic agonists and antagonists are used to modify epinephrine and norepinephrine levels released by the adrenal medulla.
Epigenetics of physical exercise is the study of epigenetic modifications to the cell genome resulting from physical exercise. Environmental factors,including physical exercise,have been shown to have a beneficial influence on epigenetic modifications. Generally,it has been shown that acute and long-term exercise has a significant effect on DNA methylation,an important aspect of epigenetic modifications.
Diabetes mellitus (DM) is a type of metabolic disease characterized by hyperglycemia. It is caused by either defected insulin secretion or damaged biological function,or both. The high-level blood glucose for a long time will lead to dysfunction of a variety of tissues.
Hepatokines are proteins produced by liver cells (hepatocytes) that are secreted into the circulation and function as hormones across the organism. Research is mostly focused on hepatokines that play a role in the regulation of metabolic diseases such as diabetes and fatty liver and include:Adropin,ANGPTL4,Fetuin-A,Fetuin-B,FGF-21,Hepassocin,LECT2,RBP4,Selenoprotein P,Sex hormone-binding globulin.
An exerkine is a signaling molecule released in response to exercise that helps mediate systemic adaptations to exercise.